US FDA places clinical hold on Rocket Pharma's gene therapy trial-February 2024-www.financetom.com

US FDA places clinical hold on Rocket Pharma's gene therapy trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA places clinical hold on Rocket Pharma's gene therapy trial

May 27, 2025 4:44 AM

May 27 (Reuters) - The U.S. Food and Drug Administration

placed a clinical hold on Rocket Pharmaceuticals' ( RCKT ) gene

therapy trial due to a serious event in one patient, the company

said on Tuesday.

Previous page： Invo Fertility Stock Is Plunging After White House Announcement Next page： Disc Medicine's Bitopertin Could See US FDA Approval by Early February 2026, Wedbush Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Invo Fertility Stock Is Plunging After White House Announcement

Oct 17, 2025

INVO Fertility Inc ( IVF ) shares are trading lower on Thursday as investors book profits following White House announcements aimed at making fertility treatments more affordable and accessible. What Happened: According to Reuters, the Trump administration made a deal with drugmaker Merck KGaA ( MKGAF ) to dramatically cut the cost of IVF medications. Under the agreement, Merck's fertility...

Disc Medicine's Bitopertin Could See US FDA Approval by Early February 2026, Wedbush Says

Oct 17, 2025

02:42 PM EDT, 10/17/2025 (MT Newswires) -- Disc Medicine's ( IRON ) drug candidate bitopertin is expected to get a priority review decision from the US Food and Drug Administration in late November or early December, which could imply regulatory approval by early February 2026, Wedbush said in a Friday note. Based on this scenario, Wedbush said it increased its...

Market Chatter: Exxon Mobil Sells Guyanese Crude Oil to Indian Refiners

Oct 17, 2025

02:41 PM EDT, 10/17/2025 (MT Newswires) -- Exxon Mobil ( XOM ) has sold 4 million barrels of Guyanese crude oil to two Indian refiners, Reuters reported Friday. According to the report, Indian Oil bought 2 million barrels of Golden Arrowhead crude, and Hindustan Petroleum acquired 2 million barrels of Liza and Unity Gold crude. Deliveries are set for late...

NDFI Credit Risk to Impact Bank Earnings in 2026, UBS Says

Oct 17, 2025

02:41 PM EDT, 10/17/2025 (MT Newswires) -- Credit concerns around non-depository financial institutions, or NDFI, lending have increased following recent high-profile bankruptcies, UBS said Friday, adding that potential NDFI losses could affect earnings of major banks such as JPMorgan Chase ( JPM ) , Bank of America ( BAC ) , and Wells Fargo ( WFC ) by 12% to...